Tips offered for safe, effective antimetabolite use

Article

Performing "safe surgery" remains as the sine qua non for using antimetabolites safely and effectively as an adjunct to trabeculectomy. However, there are some strategies that can be incorporated in the surgical technique to reduce the risk of complications resulting from the application of anti-scarring medication, said Richard K. Parrish, II, MD, at the World Ophthalmology Congress.

Performing "safe surgery" remains as the sine qua non for using antimetabolites safely and effectively as an adjunct to trabeculectomy. However, there are some strategies that can be incorporated in the surgical technique to reduce the risk of complications resulting from the application of anti-scarring medication, said Richard K. Parrish, II, MD, at the World Ophthalmology Congress.

"One cannot do a technically unsatisfactory filtration procedure and expect an anti-scarring medication to rescue a fundamental surgical error," said Dr. Parrish of the Bascom Palmer Eye Institute at the University of Miami in the United States. "Minimizing preoperative subconjunctival inflammation, surgical trauma, and immediate postoperative hypotony are concepts that were critical before we had anti-scarring agents and still are today."

However, experience with anti-scarring agents has taught several lessons. The first is the importance of never placing the filtration site inferiorly. In addition, in order to create a more diffuse posterior bleb, the flap should be fornix-based, not limbus-based, and the intraoperative mitomycin-C should be applied over a larger area (3 or 4 clock hours) versus a more limited region.

Other safety considerations include use of intraoperative 5-fluorouracil 50 mg/mL for 5 minutes as an alternative to mitomycin-C in older Caucasians undergoing primary surgery. If the choice is made to use mitomycin-C in such patients, then a lower concentration - 0.2 or 0.4 mg/ml versus 0.5 mg/mL - and for a shorter exposure time - 2 minutes versus 5 minutes - might also be considered to reduce the likelihood of creating a very thin, avascular conjunctiva.

Dr. Parrish also noted that in his personal technique, he uses a cellulose sponge to absorb any excessive mitomycin-C prior to irrigation in the hopes of preventing distribution of the agent over the surgical field.

"I have no evidence this is beneficial, but it seems to make good sense," he said.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
© 2025 MJH Life Sciences

All rights reserved.